⌘K
Atsena Therapeutics
Healthcare & Life Sciences
Recent Finacing
Series C
Recent Raise
$150M
Atsena Therapeutics is a clinical-stage gene therapy company focused on developing treatments for inherited retinal diseases such as X-linked retinoschisis and Leber congenital amaurosis type 1.
Focus Areas
Gene therapy
Clinical-stage
X-linked retinoschisis
Leber congenital amaurosis
Blindness
Genetic condition
Investors
